1351 - 1400 of 8112 Results
Title
Year
-
OPENTitle: Protein aggregation and calcium dysregulation are hallmarks of familial Parkinson’s disease in midbrain dopaminergic neuronsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00423-7Best OA location URL: https://www.nature.com/articles/s41531-022-00423-7.pdfCitation Count: 35
- Specialized Versus Generic Allied Health Therapy and the Risk of Parkinson's Disease Complications2022OPENTitle: Specialized Versus Generic Allied Health Therapy and the Risk of Parkinson's Disease ComplicationsJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 2Start Page: 223End Page: 231Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29274Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29274Citation Count: 15
-
OPENTitle: Longitudinal IgG antibody responses to Plasmodium vivax blood-stage antigens during and after acute vivax malaria in individuals living in the Brazilian AmazonJournal Name: PLOS Neglected Tropical DiseasesPublisher: Public Library of Science (PLoS)Vol: 16Issue #: 11Start Page: e0010773End Page: e0010773Publication Date:Open Access(OA) Status: OPENLicense: cc0, cc0, cc0DOI - Digital Object Identifier: 10.1371/journal.pntd.0010773Best OA location URL: https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0010773&type=printableCitation Count: 7
- Motor cortex excitability is reduced during freezing of upper limb movement in Parkinson’s disease2022OPENTitle: Motor cortex excitability is reduced during freezing of upper limb movement in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00420-wBest OA location URL: https://www.nature.com/articles/s41531-022-00420-w.pdfCitation Count: 5
-
OPENTitle: Nicotine‐Mediated Rescue of α‐Synuclein Toxicity Requires Synaptic Vesicle Glycoprotein 2 in DrosophilaJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 2Start Page: 244End Page: 255Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.29283Best OA location URL: https://doi.org/10.1002/mds.29283Citation Count: 18
-
OPENTitle: Preventing Surgery-Induced NK Cell Dysfunction Using Anti-TGF-β ImmunotherapeuticsJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 23Issue #: 23Start Page: 14608End Page: 14608Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3390/ijms232314608Best OA location URL: https://www.mdpi.com/1422-0067/23/23/14608/pdf?version=1669349103Citation Count: 0
-
OPENTitle: The associations of cerebrospinal fluid biomarkers with cognition, and rapid eye movement sleep behavior disorder in early Parkinson’s diseaseJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2022.1049118Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2022.1049118/pdfCitation Count: 4
-
OPENTitle: Dementia with Lewy bodies post-mortem brains reveal differentially methylated CpG sites with biomarker potentialJournal Name: Communications BiologyPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s42003-022-03965-xBest OA location URL: https://www.nature.com/articles/s42003-022-03965-x.pdfCitation Count: 4
-
OPENTitle: Millisecond Hydrogen/Deuterium-Exchange Mass Spectrometry Approach to Correlate Local Structure and Aggregation in α-SynucleinJournal Name: Analytical ChemistryPublisher: American Chemical Society (ACS)Vol: 94Issue #: 48Start Page: 16711End Page: 16719Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1021/acs.analchem.2c03183Best OA location URL: https://www.repository.cam.ac.uk/bitstream/1810/344774/2/article.pdfCitation Count: 13
-
OPENTitle: Potential of Non-Coding RNA as Biomarkers for Progressive Supranuclear PalsyJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 23Issue #: 23Start Page: 14554End Page: 14554Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms232314554Best OA location URL: https://www.mdpi.com/1422-0067/23/23/14554/pdf?version=1669134772Citation Count: 5
-
RESTRICTEDTitle: Spillover: The Approval of New Medications for Alzheimer’s Disease Dementia Will Impact Biomarker Disclosure Among Asymptomatic Research ParticipantsJournal Name: Journal of Alzheimer's DiseasePublisher: IOS PressVol: 90Issue #: 3Start Page: 1035End Page: 1043Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jad-220113Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794032Citation Count: 3
-
OPENTitle: The Effects of Deep Brain Stimulation in Patients with Multiple System AtrophyJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 8Start Page: 2595End Page: 2600Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-223504Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10077954Citation Count: 7
-
RESTRICTEDTitle: Comparative Effectiveness of Device-Aided Therapies on Quality of Life and Off-Time in Advanced Parkinson’s Disease: A Systematic Review and Bayesian Network Meta-analysisJournal Name: CNS DrugsPublisher: Springer Science and Business Media LLCVol: 36Issue #: 12Start Page: 1269End Page: 1283Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40263-022-00963-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40263-022-00963-9.pdfCitation Count: 14
- Screening performances of an 8-item UPSIT Italian version in the diagnosis of Parkinson’s disease2022OPENTitle: Screening performances of an 8-item UPSIT Italian version in the diagnosis of Parkinson’s diseaseJournal Name: Neurological SciencesPublisher: Springer Science and Business Media LLCVol: 44Issue #: 3Start Page: 889End Page: 895Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s10072-022-06457-2Best OA location URL: https://link.springer.com/content/pdf/10.1007/s10072-022-06457-2.pdfCitation Count: 6
-
OPENTitle: Human pericytes degrade diverse α-synuclein aggregatesJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 17Issue #: 11Start Page: e0277658End Page: e0277658Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0277658Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0277658&type=printableCitation Count: 10
-
RESTRICTEDTitle: Isolation of Human Microglia from Neuropathologically Diagnosed Cases in the Single-Cell EraJournal Name: Methods in Molecular BiologyPublisher: Springer USVol:Issue #:Start Page: 43End Page: 62Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/978-1-0716-2655-9_3Citation Count: 2
-
OPENTitle: LUBAC assembles a ubiquitin signaling platform at mitochondria for signal amplification and transport of NF‐κB to the nucleusJournal Name: The EMBO JournalPublisher: Springer Science and Business Media LLCVol: 41Issue #: 24Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.15252/embj.2022112006Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.15252/embj.2022112006Citation Count: 25
-
RESTRICTEDTitle: Somatic CNV Detection by Single-Cell Whole-Genome Sequencing in Postmortem Human BrainJournal Name: Methods in Molecular BiologyPublisher: Springer USVol:Issue #:Start Page: 205End Page: 230Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/978-1-0716-2655-9_11Citation Count: 3
-
RESTRICTEDTitle: Targeting the Complement–Sphingolipid System in COVID-19 and Gaucher Diseases: Evidence for a New Treatment StrategyJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 23Issue #: 22Start Page: 14340End Page: 14340Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms232214340Best OA location URL: https://www.mdpi.com/1422-0067/23/22/14340/pdf?version=1669106553Citation Count: 8
-
OPENTitle: BDNF rs10501087, rs1491850 and rs11030094 polymorphisms associated with delayed progression in early-stage Parkinson's diseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.1053591Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.1053591/pdfCitation Count: 0
-
OPENTitle: Multi-platform proteomic analysis of Alzheimer’s disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisomeJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-022-01113-5Best OA location URL: https://alzres.biomedcentral.com/counter/pdf/10.1186/s13195-022-01113-5Citation Count: 102
-
OPENTitle: Subjective cognitive complaints are important in PD-MCI criteria: Associations with CSF markers and cognitive declineJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 106Issue #:Start Page: 105221End Page: 105221Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.11.013Best OA location URL: http://www.prd-journal.com/article/S1353802022003819/pdfCitation Count: 3
-
RESTRICTEDTitle: Major advances in Parkinson's disease over the past two decades and future research directionsJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 12Start Page: 1076End Page: 1079Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(22)00448-3Citation Count: 12
-
RESTRICTEDTitle: Revisiting levodopa for advanced Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 12Start Page: 1063End Page: 1065Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(22)00435-5Citation Count: 1
-
RESTRICTEDTitle: Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trialJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 12Start Page: 1099End Page: 1109Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(22)00400-8Citation Count: 67
-
OPENTitle: Universal clinical Parkinson’s disease axes identify a major influence of neuroinflammationJournal Name: Genome MedicinePublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s13073-022-01132-9Best OA location URL: https://genomemedicine.biomedcentral.com/counter/pdf/10.1186/s13073-022-01132-9Citation Count: 9
-
RESTRICTEDTitle: Cell Biology of Parkin: Clues to the Development of New Therapeutics for Parkinson’s DiseaseJournal Name: CNS DrugsPublisher: Springer Science and Business Media LLCVol: 36Issue #: 12Start Page: 1249End Page: 1267Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s40263-022-00973-7Citation Count: 5
- Metagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanisms2022OPENTitle: Metagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanismsJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41467-022-34667-xBest OA location URL: https://www.nature.com/articles/s41467-022-34667-x.pdfCitation Count: 180
- Altered Cortical Palmitoylation Induces Widespread Molecular Disturbances in Parkinson’s Disease2022OPENTitle: Altered Cortical Palmitoylation Induces Widespread Molecular Disturbances in Parkinson’s DiseaseJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 23Issue #: 22Start Page: 14018End Page: 14018Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms232214018Best OA location URL: https://www.mdpi.com/1422-0067/23/22/14018/pdf?version=1668398534Citation Count: 9
-
RESTRICTEDTitle: Genotype–Phenotype Correlations for ATX‐TBP (SCA17): MDSGene Systematic ReviewJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 3Start Page: 368End Page: 377Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29278Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29278Citation Count: 7
-
OPENTitle: Movement Disorders andSARS‐CoV‐2Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: S2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13615Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448146Citation Count: 3
-
OPENTitle: APOE E4 is associated with impaired self-declared cognition but not disease risk or age of onset in Nigerians with Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00411-xBest OA location URL: https://www.nature.com/articles/s41531-022-00411-x.pdfCitation Count: 7
-
OPENTitle: Axonal Tract Reconstruction Using a Tissue-Engineered Nigrostriatal Pathway in a Rat Model of Parkinson’s DiseaseJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 23Issue #: 22Start Page: 13985End Page: 13985Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms232213985Best OA location URL: https://www.mdpi.com/1422-0067/23/22/13985/pdf?version=1668767894Citation Count: 10
-
OPENTitle: Biomarkers and non-motor symptoms as a function of motor symptom asymmetry in early Parkinson's diseaseJournal Name: NeuropsychologiaPublisher: Elsevier BVVol: 177Issue #:Start Page: 108419End Page: 108419Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neuropsychologia.2022.108419Best OA location URL: https://doi.org/10.1016/j.neuropsychologia.2022.108419Citation Count: 10
-
OPENTitle: Digitizing a Therapeutic: Development of an Augmented Reality Dual-Task Training Platform for Parkinson’s DiseaseJournal Name: SensorsPublisher: MDPI AGVol: 22Issue #: 22Start Page: 8756End Page: 8756Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/s22228756Best OA location URL: https://www.mdpi.com/1424-8220/22/22/8756/pdf?version=1668248220Citation Count: 8
-
OPENTitle: Performance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer’s diseaseJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-022-01116-2Best OA location URL: https://alzres.biomedcentral.com/counter/pdf/10.1186/s13195-022-01116-2Citation Count: 31
-
OPENTitle: Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disordersJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-022-01468-8Best OA location URL: https://actaneurocomms.biomedcentral.com/counter/pdf/10.1186/s40478-022-01468-8Citation Count: 36
-
OPENTitle: Reduced synaptic proteins and SNARE complexes in Down syndrome with Alzheimer's disease and the Dp16 mouse Down syndrome model: Impact of APP gene doseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 5Start Page: 2095End Page: 2116Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.12835Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.12835Citation Count: 10
-
OPENTitle: Compensation Strategies for Gait Impairments in Parkinson's Disease: From Underlying Mechanisms to Daily Clinical PracticeJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: S2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13616Best OA location URL: https://doi.org/10.1002/mdc3.13616Citation Count: 7
-
RESTRICTEDTitle: GALC variants affect galactosylceramidase enzymatic activity and risk of Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 146Issue #: 5Start Page: 1859End Page: 1872Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awac413Best OA location URL: https://academic.oup.com/brain/article-pdf/146/5/1859/50127735/awac413.pdfCitation Count: 11
-
OPENTitle: Genetic Testing for GBA and LRRK2 Mutations: Is it Time for Routine Use?Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: S2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13619Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13619Citation Count: 2
-
OPENTitle: The Existential Essentialism in Tremor Nosology − 7 Pitfalls, 2 Remedies, and a Path AheadJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: S2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13622Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448133Citation Count: 3
-
OPENTitle: Video-Based Facial Movement Analysis in the Assessment of Bulbar Amyotrophic Lateral Sclerosis: Clinical ValidationJournal Name: Journal of Speech, Language, and Hearing ResearchPublisher: American Speech Language Hearing AssociationVol: 65Issue #: 12Start Page: 4667End Page: 4678Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1044/2022_jslhr-22-00072Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940890Citation Count: 12
-
OPENTitle: Cerebrospinal fluid and blood profiles of transfer RNA fragments show age, sex, and Parkinson's disease‐related changesJournal Name: Journal of NeurochemistryPublisher: WileyVol: 164Issue #: 5Start Page: 671End Page: 683Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1111/jnc.15723Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.15723Citation Count: 19
-
OPENTitle: CSF ferritin in the clinicopathological progression of Alzheimer’s disease and associations with APOE and inflammation biomarkersJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 94Issue #: 3Start Page: 211End Page: 219Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2022-330052Best OA location URL: https://jnnp.bmj.com/content/jnnp/94/3/211.full.pdfCitation Count: 12
-
OPENTitle: Epidemiology meets toxicogenomics: Mining toxicologic evidence in support of an untargeted analysis of pesticides exposure and Parkinson’s diseaseJournal Name: Environment InternationalPublisher: Elsevier BVVol: 170Issue #:Start Page: 107613End Page: 107613Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.envint.2022.107613Best OA location URL: https://doi.org/10.1016/j.envint.2022.107613Citation Count: 12
- Older patients with COVID‐19 and neuropsychiatric conditions: A study of risk factors for mortality2022OPENTitle: Older patients with COVID‐19 and neuropsychiatric conditions: A study of risk factors for mortalityJournal Name: Brain and BehaviorPublisher: WileyVol: 12Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/brb3.2787Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/brb3.2787Citation Count: 2
-
OPENTitle: R1441C and G2019S LRRK2 knockin mice have distinct striatal molecular, physiological, and behavioral alterationsJournal Name: Communications BiologyPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s42003-022-04136-8Best OA location URL: https://www.nature.com/articles/s42003-022-04136-8.pdfCitation Count: 14
-
OPENTitle: Stability of motor-nonmotor subtype in early-stage Parkinson’s diseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.1040405Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.1040405/pdfCitation Count: 2
-
OPENTitle: The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development programJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.1036068Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.1036068/pdfCitation Count: 16